The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 116:838-839, March 1960
doi: 10.1176/appi.ajp.116.9.838
© 1960 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by CAHAN, R. B.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by CAHAN, R. B.

EFFICACY OF TRIFLUOPERAZINE IN CHRONIC MENTAL ILLNESS

ROBERT B. CAHAN M.D.1

1 Norristown State Hospital, Norristown, Pa.

Trifluoperazine is considered to be of limited usefulness and considerable toxicity in an elderly female population.

The 8 patients with increased muscular rigidity having 4 of their number improved by Stelazine should be contrasted with the absence of psychiatric improvement among the 8 women with muscular weakness. Investigation of this phenomenon may reveal clues to the operation of trifluoperazine.

On the positive side, no agranulocytic, hepatotoxic, or biliary static effects were noted. A therapeutic agent which can improve the ward management of one-fifth of the severely and chronically ill patients should be considered as part of the psychotherapeutic armamentarium.







Get information about faster international access.

Privacy Policy

Copyright © 1960 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org